Parallel Advisors LLC Acquires 265 Shares of HealthEquity, Inc. $HQY

Parallel Advisors LLC lifted its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 22.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,447 shares of the company’s stock after purchasing an additional 265 shares during the quarter. Parallel Advisors LLC’s holdings in HealthEquity were worth $152,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in HQY. WPG Advisers LLC bought a new stake in HealthEquity during the first quarter worth $28,000. Versant Capital Management Inc bought a new stake in HealthEquity during the first quarter worth $28,000. Northwestern Mutual Wealth Management Co. raised its position in HealthEquity by 176.4% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company’s stock worth $58,000 after acquiring an additional 418 shares in the last quarter. Larson Financial Group LLC raised its position in HealthEquity by 1,366.0% during the first quarter. Larson Financial Group LLC now owns 689 shares of the company’s stock worth $61,000 after acquiring an additional 642 shares in the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S bought a new stake in HealthEquity during the first quarter worth $65,000. Institutional investors own 99.55% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft upped their price target on shares of HealthEquity from $98.00 to $115.00 and gave the stock a “buy” rating in a research report on Thursday, June 5th. Jefferies Financial Group upped their price target on shares of HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research report on Wednesday, September 3rd. JMP Securities upped their price objective on shares of HealthEquity from $110.00 to $117.00 and gave the company a “market outperform” rating in a report on Wednesday, June 4th. Bank of America upped their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company a “buy” rating in a report on Wednesday, June 4th. Finally, The Goldman Sachs Group upped their price objective on shares of HealthEquity from $94.00 to $104.00 and gave the company a “neutral” rating in a report on Wednesday, June 4th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Buy” and a consensus price target of $119.77.

Insider Buying and Selling

In other news, EVP Michael Henry Fiore sold 1,794 shares of the firm’s stock in a transaction that occurred on Monday, July 7th. The shares were sold at an average price of $101.73, for a total value of $182,503.62. Following the completion of the transaction, the executive vice president directly owned 53,225 shares in the company, valued at approximately $5,414,579.25. This trade represents a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Delano Ladd sold 6,000 shares of the firm’s stock in a transaction that occurred on Friday, September 19th. The shares were sold at an average price of $94.11, for a total transaction of $564,660.00. Following the completion of the sale, the executive vice president directly owned 79,456 shares in the company, valued at $7,477,604.16. This represents a 7.02% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by company insiders.

HealthEquity Price Performance

HQY opened at $93.85 on Wednesday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23. The firm has a market cap of $8.09 billion, a P/E ratio of 56.88, a PEG ratio of 1.38 and a beta of 0.50. HealthEquity, Inc. has a fifty-two week low of $74.07 and a fifty-two week high of $116.65. The firm has a 50-day moving average of $92.77 and a 200 day moving average of $93.91.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.